In a much-needed and laudable development for women’s healthcare in Saudi Arabia, medical devices company TruScreen’s (ASX: TRU) distributor, Bettalife, has successfully obtained reimbursement approval from the majority of private health insurance companies in the country. With reimbursement in place, women who are insured and opt for TruScreen over the conventional Pap Smear will receive
Read MoreAhh the pap smear. The daunting, uncomfortable and downright annoying process of having a cervical swab taken to be tested for cancerous or precancerous cells, only to be repeated in 3-5 years time. Despite being an important aspect of women’s health – COVID-19, uncomfortable gyno appointments, and misinformation means that booking in for that test
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.